Regulating Laetrile: constitutional and statutory implications.
D000678:Amygdalin; D005069:Evaluation Studies as Topic; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006801:Humans; D009369:Neoplasms; D005791:Patient Care; D004364:Pharmaceutical Preparations; D018907:Privacy; D011640:Public Policy; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014486:United States Food and Drug Administration
Food, Drug, and Cosmetic Act